We are live on
!
Find out more
EC
EcoR1 Capital Portfolio holdings
AUM
$2.34B
1-Year Est. Return
204.53%
This Fund
S&P 500
This Quarter
Est. Return
-0.77%
1 Year Est. Return
+204.53%
3 Year Est. Return
+306.25%
5 Year Est. Return
+490.45%
10 Year Est. Return
+14,115.48%
AUM
$3.11B
AUM Growth
-$180M
(-5.5%)
Cap. Flow
-$9.91M
Cap. Flow
% of AUM
-0.32%
Top 10 Holdings %
Top 10 Hldgs %
73.57%
Holding
71
New
5
Increased
9
Reduced
9
Closed
13
Top Buys
| 1 |
Janux Therapeutics
JANX
|
+$40.2M |
| 2 |
Revolution Medicines
RVMD
|
+$22M |
| 3 |
Zymeworks
ZYME
|
+$22M |
| 4 |
LKFT
Lakefront Biotherapeutics American Depositary Shares
LKFT
|
+$21.1M |
| 5 |
Arvinas
ARVN
|
+$18.8M |
Top Sells
| 1 |
Zai Lab
ZLAB
|
+$66.2M |
| 2 |
VTYX
Ventyx Biosciences
VTYX
|
+$13.1M |
| 3 |
TSVT
2seventy bio
TSVT
|
+$10.7M |
| 4 |
Geron
GERN
|
+$9.75M |
| 5 |
AVEO
AVEO Pharmaceuticals, Inc.
AVEO
|
+$9.72M |
Sector Composition
| 1 | Healthcare | 99.82% |
| 2 | Financials | 0.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Prothena Corp
PRTA
$450M
| $561M | 18.08% |
11,584,280
| – | – |
|
2
Sarepta Therapeutics
SRPT
$1.83B
| $413M | 13.31% |
2,999,453
| – | – |
|
|
APLS
3
DELISTED
Apellis Pharmaceuticals
APLS
| $360M | 11.58% |
5,451,647
+268,216
| +5% | +$15.5M |
|
|
LKFT
4
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.93B
| $164M | 5.28% |
4,244,645
+513,915
| +14% | +$21.1M |
|
5
AnaptysBio
ANAB
$1.67B
| $164M | 5.27% |
7,521,024
| – | – |
|
6
Xencor
XNCR
$1.1B
| $147M | 4.74% |
5,282,516
| – | – |
|
|
MORF
7
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $145M | 4.66% |
3,846,966
-104,600
| -3% | -$3.85M |
|
|
8
Revolution Medicines
RVMD
$39.2B
| $116M | 3.73% |
5,352,183
+893,452
| +20% | +$22M |
|
9
Acadia Pharmaceuticals
ACAD
$4.45B
| $113M | 3.63% |
5,991,479
| – | – |
|
|
10
Arvinas
ARVN
$530M
| $102M | 3.27% |
3,717,788
+594,488
| +19% | +$18.8M |
|
|
11
Zymeworks
ZYME
$1.81B
| $91.2M | 2.94% |
10,087,473
+2,518,900
| +33% | +$22M |
|
|
SWTX
12
DELISTED
SpringWorks Therapeutics
SWTX
| $89.1M | 2.87% |
3,460,208
| – | – |
|
13
Kura Oncology
KURA
$1B
| $81.2M | 2.61% |
6,638,371
| – | – |
|
14
Relay Therapeutics
RLAY
$4.22B
| $68.6M | 2.21% |
4,163,824
| – | – |
|
|
15
Janux Therapeutics
JANX
$971M
| $46.4M | 1.5% |
3,838,486
+2,417,167
| +170% | +$40.2M |
|
16
Voyager Therapeutics
VYGR
$192M
| $29.7M | 0.96% |
3,851,507
-902,400
| -19% | -$7.18M |
|
17
Dyne Therapeutics
DYN
$3.92B
| $26.8M | 0.86% |
2,322,384
| – | – |
|
|
NGM
18
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $26.3M | 0.85% |
6,435,518
| – | – |
|
19
Alector
ALEC
$164M
| $25.1M | 0.81% |
4,056,548
| – | – |
|
20
Kymera Therapeutics
KYMR
$9.27B
| $23.6M | 0.76% |
796,093
| – | – |
|
21
Edgewise Therapeutics
EWTX
$4.34B
| $23.3M | 0.75% |
3,493,194
| – | – |
|
22
Nuvation Bio
NUVB
$2.03B
| $23.1M | 0.74% |
13,896,543
| – | – |
|
23
Allogene Therapeutics
ALLO
$635M
| $22.2M | 0.71% |
4,488,200
| – | – |
|
|
CNTA
24
DELISTED
Centessa Pharmaceuticals
CNTA
| $21.6M | 0.7% |
5,618,779
+386,500
| +7% | +$1.41M |
|
25
Crinetics Pharmaceuticals
CRNX
$8.88B
| $21.4M | 0.69% |
1,330,263
| – | – |
|
Similar funds
G
MC
BAM
CC
HFM
NO
ST
MFAM